help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LAATIKAINEN, A. K.
Right arrow Articles by SAARIKOSKI, S. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by LAATIKAINEN, A. K.
Right arrow Articles by SAARIKOSKI, S. V.

Am. J. Respir. Crit. Care Med., Volume 159, Number 4, April 1999, 1179-1185

Bone Mineral Density in Perimenopausal Women with Asthma
A Population-based Cross-sectional Study

ANNE K. LAATIKAINEN, HEIKKI P. J. KRÖGER, HANNU O. TUKIAINEN, RISTO J. HONKANEN, and SEPPO V. SAARIKOSKI

Departments of Respiratory Medicine, Surgery, and Obstetrics and Gynecology, Kuopio University Hospital, and Research Institute of Public Health, University of Kuopio, Kuopio, Finland

It is not known whether asthma constitutes a risk factor for osteoporosis or what the impact is of inhaled corticosteroids on bone mineral density (BMD). The study population (n = 3,222) was a random stratified sample from the Kuopio Osteoporosis Study, which included all women 47 to 56 yr of age residing in Kuopio Province, Eastern Finland. Spinal and femoral BMDs were measured using dual-energy X-ray absorptiometry. The BMD values of 119 asthmatics were cross-sectionally compared with those of 3,103 nonasthmatics. Of the 119 asthmatic women, 28 had not used corticosteroids, 65 had used oral corticosteroids, and 26 had used only inhaled corticosteroids. The asthmatics with no hormone replacement therapy (HRT) (n = 83) had lower mean spinal and femoral BMD value than did the corresponding nonasthmatics (spinal BMD, 1.083 ± 0.150 [SD] versus 1.128 ± 0.160 g/cm2, p < 0.05; femoral BMD, 0.894 ± 0.112 [SD] versus 0.929 ± 0.128 g/cm2, p < 0.05). Although BMDs were not significantly decreased in the asthmatics who had used inhaled corticosteroids, the duration of use correlated negatively with spinal BMD and was also associated with spinal BMD in multiple regression analysis. In perimenopausal women, asthma is associated with decreased bone density. This may be due to the corticosteroids rather than to the disease itself. However, HRT appears to be protective against bone loss also in asthmatics.




This article has been cited by other articles:


Home page
ChestHome page
O. Gluck and G. Colice
Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases
Chest, May 1, 2004; 125(5): 1859 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. B. Hubbard, C. J. P. Smith, L. Smeeth, T. W. Harrison, and A. E. Tattersfield
Inhaled Corticosteroids and Hip Fracture: A Population-based Case-Control Study
Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): 1563 - 1566.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Katsura and K. Kida
A Comparison of Bone Mineral Density in Elderly Female Patients With COPD and Bronchial Asthma
Chest, December 1, 2002; 122(6): 1949 - 1955.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Matsumoto, K. Ishihara, T. Hasegawa, B.-i. Umeda, A. Niimi, and M. Hino
Effects of Inhaled Corticosteroid and Short Courses of Oral Corticosteroids on Bone Mineral Density in Asthmatic Patients : A 4-Year Longitudinal Study
Chest, November 1, 2001; 120(5): 1468 - 1473.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society